Semi-Annual Statement Of Income And Retained Earnings

Kringle Pharma,Inc. - Filing #7264672

Concept 2024-10-01 to
2025-03-31
2023-10-01 to
2024-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-511,933,000 JPY
-366,746,000 JPY
Non-operating income
Non-operating income
257,000 JPY
1,275,000 JPY
Non-operating expenses
Non-operating expenses
65,000 JPY
JPY
Ordinary profit (loss)
-511,740,000 JPY
-365,471,000 JPY
Profit (loss) before income taxes
-511,740,000 JPY
-365,471,000 JPY
Income taxes - current
749,000 JPY
746,000 JPY
Profit (loss)
-512,490,000 JPY
-366,217,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.